Vericel Corp (NASDAQ:VCEL)

3.60
Delayed Data
As of 3:58pm ET
 0.00 / 0.00%
Today’s Change
2.55
Today|||52-Week Range
7.00
+18.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$85.6M

Company Description

Vericel Corp. is a regenerative medicine company which engages in the development of patient-specific, expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases. The company's research and product development involves in the development of patient specific cell products for use in regenerative medicine. Its proprietary cell-manufacturing technology enables the manufacture of Ixmyelocel-T, a patient-specific, multicellular therapy, expanded from an adult's own bone marrow, and delivered directly to damaged tissues. Vericel was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Contact Information

Vericel Corp.
64 Sidney Street
Cambridge Massachusetts 02139
P:(617) 252-7999
Investor Relations:

Employees

Shareholders

Other institutional52.90%
Mutual fund holders3.95%
Individual stakeholders0.21%

Top Executives

Dominick C. ColangeloPresident, CEO, Treasurer, Director & CAO
Daniel R. OrlandoChief Operating Officer
Gerard J. MichelChief Financial Officer & VP-Corporate Development
David ReckerChief Medical Officer
Ross TuboChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account